$ACU

ACME UNITED CORP (ACU): Results of Operations and Financial Condition

ACME UNITED CORP (ACU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 acu-ex99_1.htm EX-99.1 EX-99.1 Ex 99.1 ACME UNITED CORPORATION NEWS RELEASE CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484 Phone: (203) 254-6060 FOR IMMEDIATE RELEASE July 23, 2026 ACME UNITED REPORTS SECOND QUARTER 2026 NET SALES

Original reporting
Published Jul 23, 2026, 12:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ACU
Bullish
medium confidence
Mentioned
$ACU
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ACUBullishMed
01

Why it matters

Traders can update near-term expectations for revenue growth, gross margin trajectory, and financing/capital structure following the new $65M syndicated credit facility and the acquisition-related cash flow profile.

02

Market read

Fresh quarterly numbers plus explicit guidance on tariff-related margin pressure and acquisition integration progress create actionable inputs for earnings-model updates.

03

What to watch

My Medic is seasonal with profitability concentrated in Q4, so second-quarter earnings may understate the acquisition’s longer-term earnings power; also, gross margin improvement is partly influenced by acquisition mix.

Relevance 7/10Novelty 8/10Timing: filed pre-market today, ahead of the company’s 12:00 p.m. ET conference call

Background

Acme United filed an 8-K with its Q2 2026 results, including performance by segment and commentary on the My Medic acquisition and tariff impacts.

Company-level read

Ticker impact

$ACUBullishMedium confidence
Context

Acme United reported Q2 2026 net sales of $62.7M (+16%) and net income of $5.1M (+6%), plus margin pressure from elevated tariffs.

Expected impact

Near-term bias modestly positive on revenue and income growth, but tempered by management’s expectation that tariff-driven margin pressure continues.

Evidence & confidence

This is a primary 8-K earnings release with multiple quantified datapoints (sales, income, margins) and a specific stated expectation about tariff impacts in coming quarters, which can drive revisions to near-term margin outlook.

Market effects

Signals ongoing demand strength in safety and cutting tools, but highlights tariff-driven gross margin sensitivity for consumer and industrial product suppliers.

European sales growth (24% in USD, 19% local currency) suggests strength outside the U.S., potentially supporting regional distributor sentiment.

Tariff pass-through and sourcing cost dynamics are relevant to global supply chains for similar branded safety and cutting product companies.

Counterpoint

Despite revenue and income growth, the six-month net income declined 6% and management flags continued tariff pressure, which could limit multiple expansion.

Key entities

  • Acme United Corporation

    Reported Q2 2026 results, discussed tariff-driven margin pressure, and provided updates on the My Medic acquisition and financing.

  • My Medic

    Direct-to-consumer tactical, trauma, and emergency response products acquired in January 2026; seasonal profitability expected to be concentrated in Q4.

  • HSBC Bank USA, N.A. and City National Bank

    Part of the new $65M syndicated credit facility entered July 15, 2026.

Related articles

$ACUMed

Acme United Corp (ACU) Q2 2026 Earnings Call Highlights: Strong Sales Growth

Acme United Corp (ACU) reported Q2 2026 net sales up 16% to $63 million and net income up to $5.1 million, with EPS up 5% to $1.22. Gross margin rose to 42.6% from 41%, aided by MyMedic sales of about $4.3 million. Net debt increased to $27.3 million and free cash flow was about $15 million, while tariffs and higher SG&A weighed on results.

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$ULSMed

UL Solutions Q2 Earnings Call Highlights

UL Solutions (NYSE:ULS) reported Q2 consumer revenue of $362M, up 6.5% (6.2% organic), with adjusted EBITDA rising 24.2% to $77M and margin up 310 bps to 21.3%. Risk and compliance revenue fell 17.5% to $52M after an April 1 EHS software divestiture. Operating cash flow and free cash flow for TTM were $678M and $436M. Guidance for 2026 was reaffirmed.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.